[
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
    "title": "Kvartalsrapport Q1 2026",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a94a051544e5822f96cb831b364dd2210",
    "date": "2026-05-19",
    "period": "2026-q1",
    "form_type": "interim-report",
    "report_key": "2026:q1",
    "filename": "20260519_Isofol_Delarsrapport_Q1_2026.pdf",
    "text_chars": 32659,
    "sha256": "8c49180568c15e5e7877b572a17d0364cab49ba2ad7049d4e7b71a3f1b1d3b10",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
        "chars": 32659
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-arsredovisning-2025",
    "title": "Årsredovisning 2025",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a12d1436b8ef91ab5341635badeada46e",
    "date": "2026-04-10",
    "period": "2025-annual",
    "form_type": "annual-report",
    "report_key": "2025:annual",
    "filename": "Isofol_Arsredovisning_2025.pdf",
    "text_chars": 204995,
    "sha256": "0351fd620637e1c5f22e2296336fbf47aee355388520cb2602a261753c946c62",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
        "chars": 179969
      },
      {
        "number": 2,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
        "chars": 25024
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
    "title": "Kvartalsrapport Q4 2025",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/af4cd051abbbf1d79adb663dada035623",
    "date": "2026-02-18",
    "period": "2025-q4",
    "form_type": "year-end-report",
    "report_key": "2025:q4",
    "filename": "20260218_Isofol_Bokslutskommunike_2025.pdf",
    "text_chars": 39927,
    "sha256": "40278a6b5ac5a547ff31897a2157db338fbad145ce8cad5e37114abdcf08ef68",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
        "chars": 39927
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
    "title": "Kvartalsrapport Q3 2025",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a627cf23052d77b8a20661a77b753e194",
    "date": "2025-11-12",
    "period": "2025-q3",
    "form_type": "interim-report",
    "report_key": "2025:q3",
    "filename": "20251112_Isofol_Delarsrapport_Q3_2025.pdf",
    "text_chars": 43451,
    "sha256": "7f28877a00d64ee1f5f48a195642bc8f59665c7b40e20049568be9d0f87c1a45",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
        "chars": 43451
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
    "title": "Kvartalsrapport Q2 2025",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/ab5bbf6f23332371e4710057719a0e648",
    "date": "2025-08-26",
    "period": "2025-q2",
    "form_type": "interim-report",
    "report_key": "2025:q2",
    "filename": "20250826_Isofol_Delarsrapport_Q2_2025.pdf",
    "text_chars": 39006,
    "sha256": "e381dab161da96be93503865cb56f5333a2d89e9eacbdf4de61813bbac6f1da8",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
        "chars": 39006
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
    "title": "Kvartalsrapport Q1 2025",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a4e3094058e35d8dddd58ce6aae6499c3",
    "date": "2025-05-21",
    "period": "2025-q1",
    "form_type": "interim-report",
    "report_key": "2025:q1",
    "filename": "20250521_Isofol_Delarsrapport_Q1_2025_final.pdf",
    "text_chars": 33965,
    "sha256": "1c80379a14ac40e1ad27d4eaa65eb457479124a8b6dd7d041de5f73f9e41600b",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
        "chars": 33965
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-arsredovisning-2024",
    "title": "Årsredovisning 2024",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/aba6d73344c5e9bd4360f6fa6734d66ef",
    "date": "2025-04-11",
    "period": "2024-annual",
    "form_type": "annual-report",
    "report_key": "2024:annual",
    "filename": "Isofol_Arsredovisning_2024.pdf",
    "text_chars": 201784,
    "sha256": "f97cd8c3aa77ec1729fac9f7530958ddc93b3fedad93f133d43534becb3e0885",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
        "chars": 177507
      },
      {
        "number": 2,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
        "chars": 24275
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
    "title": "Kvartalsrapport Q4 2024",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/ad98d022eeb2b9b89d9881402e4e933b1",
    "date": "2025-02-19",
    "period": "2024-q4",
    "form_type": "year-end-report",
    "report_key": "2024:q4",
    "filename": "20250219_Isofol_Bokslutskommunike_2024.pdf",
    "text_chars": 39667,
    "sha256": "0b823cc1c1e63134b2d5985766e994d3c8cfc52863f8bd33fbc5ebd6559a2024",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
        "chars": 39667
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
    "title": "Kvartalsrapport Q3 2024",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/ad8adca4674ca0d2a4db155a9e8a7a450",
    "date": "2024-11-12",
    "period": "2024-q3",
    "form_type": "interim-report",
    "report_key": "2024:q3",
    "filename": "20241112_Isofol_Delarsrapport_Q3_2024_Final.pdf",
    "text_chars": 40325,
    "sha256": "7a278edff0fc15b3d6137ba72239576aca8730ef77af21e416ce9a318a5c1b45",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
        "chars": 40325
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
    "title": "Kvartalsrapport Q2 2024",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a7d48a6679628680da42340de12ba69d7",
    "date": "2024-08-21",
    "period": "2024-q2",
    "form_type": "interim-report",
    "report_key": "2024:q2",
    "filename": "20240821_Isofol_Halvarsrapport_Q2_2024_Final.pdf",
    "text_chars": 37391,
    "sha256": "c940e5a941818b110d8ccd64b5a29da94883b6130020954dce84b423fc63c5cf",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
        "chars": 37391
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
    "title": "Kvartalsrapport Q1 2024",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/af85082cf68e17b2feb31a3a697929511",
    "date": "2024-05-08",
    "period": "2024-q1",
    "form_type": "interim-report",
    "report_key": "2024:q1",
    "filename": "20240508_Isofol_Delarsrapport_Q1_2024_Final.pdf",
    "text_chars": 33336,
    "sha256": "bfdda2573b40bfb0b225aa2c112c05c96e0a19fdc8bd7db148383f6050795c0e",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
        "chars": 33336
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-arsredovisning-2023",
    "title": "Årsredovisning 2023",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/aa820e256acac7ccab25d41c37090757d",
    "date": "2024-04-16",
    "period": "2023-annual",
    "form_type": "annual-report",
    "report_key": "2023:annual",
    "filename": "Isofol_Arsredovisning_2023_final.pdf",
    "text_chars": 186610,
    "sha256": "621cd17ddbea35b77a8fefc759e64201c1378cd4f97ae69af188625f52803fb7",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
        "chars": 179498
      },
      {
        "number": 2,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
        "chars": 7110
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
    "title": "Kvartalsrapport Q4 2023",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a7602ef9b2b257549a8fe1bd4fe653349",
    "date": "2024-02-20",
    "period": "2023-q4",
    "form_type": "year-end-report",
    "report_key": "2023:q4",
    "filename": "02191521.pdf",
    "text_chars": 39153,
    "sha256": "581a8e083b965bd9df8697fb5b1f1c9473150ca029bbf9f537e828bdf91f5191",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
        "chars": 39153
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
    "title": "Kvartalsrapport Q3 2023",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a1aebb2df992cfd76ff2c5291a77df6c8",
    "date": "2023-11-10",
    "period": "2023-q3",
    "form_type": "interim-report",
    "report_key": "2023:q3",
    "filename": "11092219.pdf",
    "text_chars": 48615,
    "sha256": "5f5a0f6ce2caf510301dd75dcdedd98b8b59b786c1ecbaa64b194f3c234530a6",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
        "chars": 48615
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
    "title": "Kvartalsrapport Q2 2023",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a9e9f689ce594cebf31181362f4489de2",
    "date": "2023-08-22",
    "period": "2023-q2",
    "form_type": "interim-report",
    "report_key": "2023:q2",
    "filename": "20230822_Isofol_Halvarsrapport_Q2_2023_ISO-372_final.pdf",
    "text_chars": 48576,
    "sha256": "dfc41859f861523d002b9d4fc5bbfa568547f4828e8ee60412b2670d8292398d",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
        "chars": 48576
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
    "title": "Kvartalsrapport Q1 2023",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/acccded929db5e3f2c6b18045e5036e33",
    "date": "2023-05-03",
    "period": "2023-q1",
    "form_type": "interim-report",
    "report_key": "2023:q1",
    "filename": "20230503_Isofol_Delarsrapport_Q1_2023_ISO-345_final.pdf",
    "text_chars": 43718,
    "sha256": "e3d6476b33400d7e168c5e7e0964756cc0dc5a1b2ae984a1afc9267d0f4cabfe",
    "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
    "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
        "chars": 43718
      }
    ]
  },
  {
    "doc_id": "mfn-mfn-bolagssida-och-bolagsmetadata",
    "title": "MFN bolagssida och bolagsmetadata",
    "source": "MFN",
    "source_class": "mfn",
    "source_url": "https://mfn.se/all/a/isofol-medical",
    "date": null,
    "period": null,
    "form_type": "company-page",
    "report_key": null,
    "filename": "company.txt",
    "text_chars": 12822,
    "sha256": "e8aec607a19a90818f8bc3e7e14fd74d47c5fb3b7d32c58ffaf71bdc29f2cfcd",
    "url": "/company/isofol-medical/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
    "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
    "txt_url": "/company/isofol-medical/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/isofol-medical/documents/mfn-mfn-bolagssida-och-bolagsmetadata/part-001.html",
        "chars": 12822
      }
    ]
  }
]